eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Submit a Response to This Article
No eLetters have been published for this article.
Article Tools
- The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Amplification of downstream signaling by AXL receptor tyrosine kinase alters the migratory response of breast cancer cells.